Medical Researches
Moderately Effective
Based on 15 Researches
Vitamin D3 mitigates gastric injuryVitamin D3 mitigates aspirin-induced gastric injury by modulating gastrokines, E-cadherin, and inhibiting NLRP3 and NF-κB/MMP-9 signaling pathway.
Focused study on aspirin ulcers
We explored the effects of Vitamin D3 on stomach ulcers caused by aspirin, focusing specifically on how it influences certain molecules in the stomach lining. In our study, we divided 24 rats into four groups: a control group, a group receiving Vitamin D3 without any gastric injury, a group with aspirin-induced gastric injuries, and a group treated with Vitamin D3 after such injuries occurred.
Our findings were quite promising. Vitamin D3 seemed to play a protective role against the damage caused by aspirin. It significantly increased levels of important protective molecules like E-Cadherin, GKN1 (a type of gastrokine), and mucin 5AC. These molecules are essential for maintaining the integrity of the stomach lining, helping to mitigate the effects of oxidative stress and inflammation often seen in gastric injuries.
Furthermore, Vitamin D3 treatment helped improve both the structure and function of gastric tissue. By reducing inflammation pathways, particularly those involving NLRP3 and NF-κB, Vitamin D3 demonstrated its potential as a protective agent in the context of aspirin-induced gastric injury.
Read More
Vitamin D3 enhances colitis treatmentCo-administration of 1,25-dihydroxyvitamin D3 and infliximab improves colitis in mice by modulating Treg differentiation.
Limited standalone effectiveness observed
We conducted an investigation into how vitamin D3 (VitD3) works in conjunction with infliximab (IFX) to improve conditions in a mouse model of ulcerative colitis (UC). Our study revealed that this combination therapy not only alleviates symptoms but also helps reduce harmful intestinal inflammation.
Utilizing a model for colitis induced by dextran sulfate sodium, we evaluated the effectiveness of co-administering VitD3 with different doses of IFX. The results were impressive: when IFX was paired with VitD3, it resulted in better clinical outcomes and less intestinal inflammation compared to IFX alone.
Specifically, we saw improvements in clinical signs and pathology, along with a reduction in inflammatory markers. Notably, the combination therapy also enhanced the differentiation of regulatory T cells (Tregs) and increased levels of IL-10, both of which play critical roles in managing inflammation. Our findings suggest that this complementary approach could be a promising alternative for patients who cannot tolerate standard treatments.
Read More
Co-delivery improves colitis treatmentAn efficient co-delivery system based on multilayer structural nanoparticles for programmed sequential release of resveratrol and vitamin D3 to combat dextran sodium sulfate-induced colitis in mice.
Moderate relevance due to combination
We investigated how the combination of resveratrol and vitamin D3 could help manage symptoms of ulcerative colitis in mice, especially in the context of a specially designed delivery system. Through the use of multilayer structural nanoparticles, we were able to efficiently encapsulate both compounds to enhance their stability and effectiveness.
In our evaluation, we observed that these nanoparticles successfully released vitamin D3 and resveratrol in a controlled manner, particularly in simulated intestinal environments. This sequential release means that the components are delivered in a timed fashion to potentially maximize their benefits.
Not only did we find that this system improved the symptoms of colitis—like weight loss and inflammation—but it also seemed to support the overall health of the colon tissue. The study's results indicated a significant reduction in inflammation markers and oxidative stress in the mice treated with this co-delivery of vitamins.
While we initially aimed to assess the standalone benefit of vitamin D3, it was challenging to isolate its effects because of the dual approach. Thus, while we can assert that the combination helped alleviate symptoms, more research would be necessary to fully understand the specific role that vitamin D3 plays in this treatment.
Read More
We conducted a thorough investigation into how vitamin D3 affects inflammation in ulcerative colitis (UC). Our study involved both UC patients and a specialized mouse model to explore the anti-inflammatory properties of 1,25-dihydroxyvitamin D (the active form of vitamin D).
Through various techniques, including RNA sequencing and chromatin assays, we unearthed a significant finding: vitamin D3 can inhibit the activation of an inflammatory protein known as NLRP6. It turns out that vitamin D3 does this by binding to specific sites in the NLRP6 gene, ultimately reducing inflammation associated with UC.
Importantly, we observed that vitamin D3 showed both preventive and therapeutic benefits in our UC mouse model, indicating its potential as a treatment option for managing symptoms of this condition. This exciting discovery not only sheds light on a new mechanism for vitamin D3's action but also points to its promise for clinical applications in inflammation-related diseases.
Read More
Vitamin D3 lowers ulcerative colitis inflammationVitamin D Reduces the Helper T Cells 17 (Th17) Differentiation in Patients with Ulcerative Colitis by Targeting Long Non-coding RNA (lncRNA) OIP5-AS1/miR-26a-5p/IL-6 Axis.
Moderate relevance to vitamin D effects
We investigated how vitamin D3 affects ulcerative colitis (UC) by examining its influence on immune responses. The study involved measuring serum levels of vitamin D, along with Interferon-γ (IFN-γ) and Interleukin (IL)-17 in patients with UC.
We found that patients with UC had lower vitamin D levels, which were negatively correlated with IL-17, a key player in inflammation. When we treated immune cells with calcitriol, the active form of vitamin D, we observed a decrease in a long non-coding RNA known as OIP5-AS1. This lncRNA interacts with microRNA (miR)-26a-5p and plays a significant role in regulating inflammation.
Our findings suggest that vitamin D3 may help reduce Th17 cell differentiation and IL-6 expression, indicating potential therapeutic benefits in managing UC. In experiments involving mice, calcitriol showed promise in alleviating colitis symptoms through its action on the OIP5-AS1 pathway.
Read More
User Reviews
The Vitamin D3 helped heal my mouth ulcer swiftly.
My doctor prescribed 5000ME of Vitamin D3 for suspected coronavirus. I typically take 2000ME regularly. Vitamin D3 is vital for the immune system and helps with calcium metabolism. It prevents respiratory infections and supports recovery from various ailments, including ulcers. Always consult a doctor before dosing.
Read More
I love this product! Our family uses it for prevention. I've noticed that my facial skin has improved, and my prior mouth ulcers heal significantly quicker and with less pain when I take Vitamin D. There has also been an unexpected improvement in my cervical erosion.
During the pandemic, I consider Vitamin D essential. After completing my course, my leg ulcers disappeared.
The quality is excellent, and its benefits include aiding throat issues and colds, acting as a natural antibiotic. The pleasant smell enhances its appeal, and it's suitable for both adults and children. It has effectively supported my immunity and aids in healing ulcers. The dosage is appropriate and the effects are impressive.
Read More